Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

HIV protease inhibitor under evaluation at Pharmacia & Upjohn

Sep. 6, 1996

Antisense anti-HIV agent heading for clinical trials

Sep. 6, 1996

Serostim FDA-approved for cachexia in AIDS patients

Aug. 30, 1996

Protease inhibitors described by Shionogi

Aug. 30, 1996

Gene mutancy linked to natural HIV-1 infection resistance

Aug. 30, 1996

Genetic sequence of AIDS-related disease revealed

Aug. 30, 1996

Cytel receives phase I SBIR grant for AIDS vaccine development

Aug. 30, 1996

Paracelsian improves HIV-1 system model

Aug. 30, 1996

Toyama reveals anti-HIV quinolones

Aug. 30, 1996

Protease inhibitors from Sankyo

Aug. 23, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...